LY2603618 , ≥98% , 911222-45-2
CAS NO.:911222-45-2
Empirical Formula: C18H22BrN5O3
Molecular Weight: 436.3
MDL number: MFCD18633253
| Pack Size | Price | Stock | Quantity |
| 5MG | RMB592.80 | In Stock |
|
| 10MG | RMB959.20 | In Stock |
|
| 50MG | RMB3199.20 | In Stock |
|
| others | Enquire |
PRODUCT Properties
| Boiling point: | 503.1±50.0 °C(Predicted) |
| Density | 1.461 |
| storage temp. | -20°C |
| solubility | Soluble in DMSO (up to 10 mg/ml) |
| form | solid |
| pka | 12.06±0.70(Predicted) |
| color | Off-white |
| Stability: | Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months. |
| InChI | 1S/C18H22BrN5O3/c1-11-5-16(27-10-13-8-20-3-4-26-13)15(6-14(11)19)23-18(25)24-17-9-21-12(2)7-22-17/h5-7,9,13,20H,3-4,8,10H2,1-2H3,(H2,22,23,24,25)/t13-/m0/s1 |
| InChIKey | SYYBDNPGDKKJDU-ZDUSSCGKSA-N |
| SMILES | N(C1=CC(Br)=C(C)C=C1OC[C@H]1OCCNC1)C(NC1=NC=C(C)N=C1)=O |
Description and Uses
LY2603618 (911222-45-2) is a potent (IC50?= 7nM) and selective (>1000x over Chk2) Checkpoint kinase 1 (Chk1) inhibitor.1?Chk1 is an important regulator of the DNA damage response – combination treatment of LY2603618 with other chemotherapeutic agents significantly increased tumor growth inhibition when compared to chemotherapeutic alone.2,3,4?LY2603618 caused a dramatic suppression of cell growth in MCF-7 and MDA-MB-231 human breast cancer cells?via?Chk1 inhibition induced upregulation of replication stress caused by oncogenes.5
LY2603618 is a selective Chk1 inhibitor that can treat idiopathic pulmonary fibrosis.
Safety
| WGK Germany | WGK 3 |
| HS Code | 29349990 |
| Storage Class | 11 - Combustible Solids |






